ワシントンにおける1型糖尿病の臨床試験
ワシントン内の拠点で、1型糖尿病に関する20件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
Type 1 Diabetes Extension Study
- Benaroya Research Institute, Seattle
被験者募集中観察研究
8歳〜35歳 · 全性別 · 2026/09/18更新 · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
被験者募集中第2相
18歳〜69歳 · 全性別 · 2026/09/15更新 · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
- MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
被験者募集中第3相
1歳〜25歳 · 全性別 · 2026/09/14更新 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
被験者募集中第1/2相
12歳〜35歳 · 全性別 · 2026/09/11更新 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Benaroya Research Institute, Seattle
被験者募集中第2相
4歳〜34歳 · 全性別 · 2026/09/09更新 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Benaroya Research Institute, Seattle
被験者募集中第2相
8歳〜45歳 · 全性別 · 2026/09/08更新 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Seattle Children's Hospital, Seattle
被験者募集中第1/2相
9歳〜20歳 · 全性別 · 2026/09/02更新 · NCT07061574SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason, Seattle
- Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
被験者募集中第2相
5歳〜40歳 · 全性別 · 2026/08/24更新 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Washington, Seattle
被験者募集中
18歳〜65歳 · 全性別 · 2026/07/16更新 · NCT06880835Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/02更新 · NCT05822609Kidney Precision Medicine Project
- University of Washington, Seattle
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/14更新 · NCT04334707Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- Rainier Clinical Reseach Center, Renton
被験者募集中
18歳〜65歳 · 全性別 · 2026/04/09更新 · NCT07296276Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Rainier Clinical Research Center, Renton
被験者募集中第2相
18歳〜50歳 · 全性別 · 2026/04/06更新 · NCT06964087Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/03/24更新 · NCT06217302Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
被験者募集中第3相
18歳〜49歳 · 全性別 · 2026/03/04更新 · NCT05819138Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Seattle Children's, Seattle
被験者募集中
16歳〜19歳 · 全性別 · 2025/12/30更新 · NCT07292558EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Benaroya Research Institute, Seattle
被験者募集中観察研究
70歳以下 · 全性別 · 2025/12/19更新 · NCT03369821InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Seattle Children's, Seattle
被験者募集中
12歳以上 · 全性別 · 2025/12/16更新 · NCT06384911TrialNet Pathway to Prevention of T1D
- Benaroya Research Institute, Seattle
被験者募集中観察研究健康なボランティア歓迎
2歳〜45歳 · 全性別 · 2025/07/01更新 · NCT00097292MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
被験者募集中第1相
12歳〜25歳 · 全性別 · 2025/06/13更新 · NCT05065372ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。